MEETINGS - Seminar on FDA Approval Process for Medical Devices (UK) September 2002:
This article was originally published in Clinica
Management Forum is hosting a seminar on the FDA Approval Process for Medical Devices on September 19-20 2002 at The Rembrandt Hotel, London, UK. The seminar will focus on new changes to the medical device regulations and provide an overview to the submission of documents to the FDA for approval of medical device products. It will include the requirements for an Investigational Device Exemption and the contents of a post-market approval as well as advice on maintaining an ongoing relationship with the FDA. Further details from Management Forum on tel: +44 (0)1483 570 099; fax: +44 (0)1483 536 424; email: email@example.com www.management-forum.co.uk
You may also be interested in...
Liquid biopsy start-up Grail Inc. announced that a study of almost 6,700 participants found that its blood test could detect more than 50 types of cancer with a low false-positive rate. See what Minetta Liu, study co-lead author and a Mayo Clinic professor of oncology, had to say about the research.
Sanofi’s next-generation meningococcal vaccine, broader use of Bristol-Myers Squibb’s Reblozyl move toward approval; United Therapeutics foreshadows Trevyent regulatory difficulties.
Biopharma is working on a reputation renaissance as the public looks to industry for treatments and vaccines for the COVID-19 epidemic and drug pricing concerns take a back seat.